Zirconium dihydride

Endpoint summary

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records

Reference

Endpoint:

acute toxicity: oral

Type of information:

experimental study

Adequacy of study:

key study

Study period:

July 2016 (Protocol approved) - February 2017 (Final report signed)

Reliability:

1 (reliable without restriction)

Qualifier:

according to guideline

Guideline:

OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)

Version / remarks:

adopted on 17 December 2001

Deviations:

no

Qualifier:

according to guideline

Guideline:

EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)

Deviations:

no

Qualifier:

according to guideline

Guideline:

EPA OPPTS 870.1100 (Acute Oral Toxicity)

Deviations:

no

GLP compliance:

yes (incl. QA statement)

Test type:

acute toxic class method

Limit test:

no

Species:

rat

Strain:

Sprague-Dawley

Sex:

female

Details on test animals or test system and environmental conditions:

TEST ANIMALS
- Source: Envigo RMS s.r.l., San Pietro al Natisone (UD), Italy
- Females (if applicable) nulliparous and non-pregnant: yes
- Age at study initiation: 6-7 weeks old
- Weight range at arrival: 148.4 - 184.3 grams and 157 -159 grams
- Fasting period before study: Food was removed from the cages overnight prior to dosing (Day -1) and was made available approximately 4 hours after dosing.
- Housing:Polisulphone solid bottomed cages measuring 59.5×38×20 cm with nesting material provided into suitable bedding bags
- Diet (e.g. ad libitum): 4 RF 18 (Mucedola S.r.l., Via G. Galilei, 4, 20019, Settimo Milanese (MI) Italy) - ad libitum throughout the study except for the dosing
- Water (e.g. ad libitum): Drinking water supplied to each cage via a water bottle - ad libitum
- Acclimation period: At least 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 °C±2 °C
- Humidity (%): 55%±15%
- Air changes (per hr): Approximately 15 to 20 air changes per hour
- Photoperiod (hrs dark / hrs light): Artificial (fluorescent tubes), daily light/dark cycle of 12/12 hours

IN-LIFE DATES: From: To: All animals were sacrificed on Day 15.

Route of administration:

oral: gavage

Vehicle:

other: 1% aqueous solution of carboxymethylcellulose

Doses:

30, 200 and 500 mg/mL

No. of animals per sex per dose:

Three females per group --> 4 groups: 300 mg/kg (2 times), 2000 mg/kg (2 times)
5000 mg/kg (1 female, one time) and (2 females for the second time)

Control animals:

no

Details on study design:

A first group of 3 female animals was dosed at a level of 300mg/kg (Step 1). Mortality did not occur. A second group, similarly composed, was then dosed at the same dose level (Step 2). No mortality occurred. A third group was dosed at 2000mg/kg. No death occurred. Therefore a fourth group was dosed at the same dose level. Since no nortality was seen, another female animal was dosed at 5000mg/kg and subsequently another two female animals were dosed
at the same dose level. Mortality did not occur. No further doses were investigated, since the objective of the study had been achieved.

Statistics:

No

Key result

Sex:

female

Dose descriptor:

other: Acute Toxicity expected (ATE)

Effect level:

> 5 000 mg/kg bw

Based on:

test mat.

Mortality:

No mortality was observed in any groups, at any dose level tested (300, 2000 and 5000mg/kg).

Clinical signs:

No clinical signs was observed in any groups, at any dose level tested (300, 2000 and 5000mg/kg).

Body weight:

Changes in body weight observed during the study were within the expected range for this strain and age of animals.

Gross pathology:

No abnormalities were observed at necropsy examination performed on all animals dosed at 300, 2000 and 5000mg/kg, and in particular in the gastrointestinal
tract, at the end of the observation period.

Interpretation of results:

other: Not classified

Conclusions:

The acute toxicity of ZrH2 was investigated following a single oral administration (10mL/kg in 1% carboxymethylcellulose) to the Sprague Dawley rat, followed by a 14-day observation period. No mortality occurred and no signs of toxicity were observed in all animals following dosing at 300, 2000 and 5000mg/kg.
These results indicate that the test item ZrH2 did not induce toxic effects in the rat, following oral administration of a single dose at a level of 5000mg/kg. The lack of mortality demonstrates the acute toxicity expected (ATE) to be greater than 5000mg/kg body weight.

Executive summary:

The acute toxicity of ZrH2 was investigated following a single oral administration to the Sprague Dawley rat, followed by a 14-day observation period.

- A first group of 3 female animals was initially dosed at 300mg/kg (Step 1). No mortality occurred and no clinical signs were observed.

- A second group of 3 female animals was then dosed at the same dose level (Step 2). No death occurred and no clinical signs were noted.

- A third group of 3 female animals was dosed at 2000mg/kg (Step 3). No mortality occurred and no clinical signs were observed.

- A single female animal was dosed at 5000mg/kg (Step 5). Since no mortality occurred, other 2 female animals were dosed at the same dose level. No death was seen and no clinical signs were noted.

Body weight changes recorded during the study were within the expected range for this strain and age of animals.

No abnormalities were observed at necropsy examination performed at the end of the observation period on animals of all groups.

Conclusion: These results indicate that the test item ZrH2 did not induce toxic effects in the rat following oral administration of a single dose at a level of 5000mg/kg. The lack of mortality demonstrates the acute toxicity expected (ATE) to be greater than 5000mg/kg body weight.

Endpoint conclusion

Endpoint conclusion:

no adverse effect observed

Dose descriptor:

discriminating dose

Value:

5 000 mg/kg bw

Quality of whole database:

Lab report (RTC, Italy - 15 February 2017)

Acute toxicity: via inhalation route

Endpoint conclusion

Endpoint conclusion:

no study available

Acute toxicity: via dermal route

Endpoint conclusion

Endpoint conclusion:

no study available